275 related articles for article (PubMed ID: 35958947)
1. Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation.
Erol A
Cancer Manag Res; 2022; 14():2339-2356. PubMed ID: 35958947
[TBL] [Abstract][Full Text] [Related]
2. SPATA2 restricts OTULIN-dependent LUBAC activity independently of CYLD.
Griewahn L; Müller-Foxworth M; Peintner L; Wissler M; Weiss M; Brauns-Schubert P; Massoumi R; Borner C; Groß O; Yabal M; Charvet C; Maurer U
Cell Rep; 2023 Jan; 42(1):111961. PubMed ID: 36640323
[TBL] [Abstract][Full Text] [Related]
3. Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN.
Takiuchi T; Nakagawa T; Tamiya H; Fujita H; Sasaki Y; Saeki Y; Takeda H; Sawasaki T; Buchberger A; Kimura T; Iwai K
Genes Cells; 2014 Mar; 19(3):254-72. PubMed ID: 24461064
[TBL] [Abstract][Full Text] [Related]
4. SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.
Elliott PR; Leske D; Hrdinka M; Bagola K; Fiil BK; McLaughlin SH; Wagstaff J; Volkmar N; Christianson JC; Kessler BM; Freund SM; Komander D; Gyrd-Hansen M
Mol Cell; 2016 Sep; 63(6):990-1005. PubMed ID: 27591049
[TBL] [Abstract][Full Text] [Related]
5. SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death.
Schlicher L; Wissler M; Preiss F; Brauns-Schubert P; Jakob C; Dumit V; Borner C; Dengjel J; Maurer U
EMBO Rep; 2016 Oct; 17(10):1485-1497. PubMed ID: 27458237
[TBL] [Abstract][Full Text] [Related]
6. SPATA2 links CYLD to the TNF-α receptor signaling complex and modulates the receptor signaling outcomes.
Wagner SA; Satpathy S; Beli P; Choudhary C
EMBO J; 2016 Sep; 35(17):1868-84. PubMed ID: 27307491
[TBL] [Abstract][Full Text] [Related]
7. LUBAC and OTULIN regulate autophagy initiation and maturation by mediating the linear ubiquitination and the stabilization of ATG13.
Chu Y; Kang Y; Yan C; Yang C; Zhang T; Huo H; Liu Y
Autophagy; 2021 Jul; 17(7):1684-1699. PubMed ID: 32543267
[TBL] [Abstract][Full Text] [Related]
8. A pro-inflammatory role of deubiquitinating enzyme cylindromatosis (CYLD) in vascular smooth muscle cells.
Liu S; Lv J; Han L; Ichikawa T; Wang W; Li S; Wang XL; Tang D; Cui T
Biochem Biophys Res Commun; 2012 Mar; 420(1):78-83. PubMed ID: 22406061
[TBL] [Abstract][Full Text] [Related]
9. LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes.
Draber P; Kupka S; Reichert M; Draberova H; Lafont E; de Miguel D; Spilgies L; Surinova S; Taraborrelli L; Hartwig T; Rieser E; Martino L; Rittinger K; Walczak H
Cell Rep; 2015 Dec; 13(10):2258-72. PubMed ID: 26670046
[TBL] [Abstract][Full Text] [Related]
10. Expression of deubiquitinases in human gingiva and cultured human gingival fibroblasts.
Fu YW; Xu HZ
BMC Oral Health; 2021 Jun; 21(1):290. PubMed ID: 34092220
[TBL] [Abstract][Full Text] [Related]
11. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
12. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
[TBL] [Abstract][Full Text] [Related]
13. Cellular and Mathematical Analyses of LUBAC Involvement in T Cell Receptor-Mediated NF-κB Activation Pathway.
Oikawa D; Hatanaka N; Suzuki T; Tokunaga F
Front Immunol; 2020; 11():601926. PubMed ID: 33329596
[TBL] [Abstract][Full Text] [Related]
14. LUBAC regulates NF-κB activation upon genotoxic stress by promoting linear ubiquitination of NEMO.
Niu J; Shi Y; Iwai K; Wu ZH
EMBO J; 2011 Aug; 30(18):3741-53. PubMed ID: 21811235
[TBL] [Abstract][Full Text] [Related]
15. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
[TBL] [Abstract][Full Text] [Related]
16. MUC1 oncoprotein activates the IkappaB kinase beta complex and constitutive NF-kappaB signalling.
Ahmad R; Raina D; Trivedi V; Ren J; Rajabi H; Kharbanda S; Kufe D
Nat Cell Biol; 2007 Dec; 9(12):1419-27. PubMed ID: 18037881
[TBL] [Abstract][Full Text] [Related]
17. Loss of CYLD might be associated with development of salivary gland tumors.
Fukuda M; Hiroi M; Suzuki S; Ohmori Y; Sakashita H
Oncol Rep; 2008 Jun; 19(6):1421-7. PubMed ID: 18497946
[TBL] [Abstract][Full Text] [Related]
18. CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.
Lork M; Verhelst K; Beyaert R
Cell Death Differ; 2017 Jul; 24(7):1172-1183. PubMed ID: 28362430
[TBL] [Abstract][Full Text] [Related]
19. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.
Jono H; Lim JH; Chen LF; Xu H; Trompouki E; Pan ZK; Mosialos G; Li JD
J Biol Chem; 2004 Aug; 279(35):36171-4. PubMed ID: 15226292
[TBL] [Abstract][Full Text] [Related]
20. Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-κB activation.
Nagabhushana A; Bansal M; Swarup G
PLoS One; 2011 Mar; 6(3):e17477. PubMed ID: 21408173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]